You, Kyu Sic <br/><br/>
Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.  [electronic resource] 

 -  International journal of oncology  Mar 2018 
 - 828-840 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2018.4244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Gene Knockdown Techniques<br/>Heterocyclic Compounds, 3-Ring--pharmacology<br/>Humans<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>RNA, Small Interfering--metabolism<br/>Regulatory-Associated Protein of mTOR--genetics<br/>Ribosomal Protein S6--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Triple Negative Breast Neoplasms--drug therapy